Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanisms and Interventions Addressing Accelerated Cardiovascular Disease Risk in Women With Endometriosis

NCT05059626 is registered in ClinicalTrials.gov with Penn State University as lead sponsor.

NCT NCT05059626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05059626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanisms and Interventions Addressing Accelerated Cardiovascular Disease Risk in Women With Endometriosis
Lead sponsor
Penn State University
Phase
Phase 4
Overall status
Enrolling by invitation
Start date
December 1, 2023
Completion date
December 31, 2026
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis